Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations

Chemical Research in Toxicology

Volumn 21, Issue 8, 2008, Pages 1524-1529

  Sogorb, Miguel A ^a   García Argüelles, Sara ^a   Carrera, Victoria ^a   Vilanova, Eugenio ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHLORPYRIFOS; LIPOPROTEIN; PARAOXON; SERUM ALBUMIN;

ARTICLE; DETOXIFICATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HYDROLYSIS; IN VIVO STUDY; INTOXICATION; MALE; PROTEIN FUNCTION;

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; HUMANS; HYDROLYSIS; MALE; METABOLIC DETOXICATION, DRUG; ORGANOPHOSPHORUS COMPOUNDS; PARAOXON; SERUM ALBUMIN;

ANIMALIA; MUS;

EID: 51449095739     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx800075x     Document Type: Article

References (39)

1. Costa, L. G., Vitalone, A., Cole, T. B., and Furlong, C. E. (2005) Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69, 541-550.
2. Mackness, M., and Mackness, B. (2004) Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? Free Radical Biol. Med. 37, 1317-1323.
3. Jakubowski, H. (2000) Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J. Biol. Chem. 75, 3957-3962.
4. Aviram, M., and Rosenblat, M. (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical Biol. Med. 37, 1304-1316.
5. Rosenblat, M., Gaidukov, L., Khersonsky, O., Vaya, J., Oren, R., Tawfik, D. S., and Aviram, M. (2006) The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J. Biol. Chem. 281, 7657-7665.
6. Mackness, B., Quarck, R., Verreth, W., Mackness, M., and Holvoet, P. (2006) Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler., Thromb., Vasc. Biol. 26, 1545-1550.
7. Shih, D. M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., and Lusis, A. J. (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394, 284-287.
8. Durrington, P. N., Mackness, B., and Mackness, M. I. (2001) Paraoxonase and atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 21, 473-480.
9. Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., and Mackness, M. I. (2001) Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler., Thromb., Vasc. Biol. 21, 1451-1457.
10. Gur, M., Aslan, M., Yildiz, A., Demirbag, R., Yilmaz, R., Selek, S., Erel, O., and Ozdogru, I. (2006) Paraoxonase and arylesterase activities in coronary artery disease. Eur. J. Clin. Invest. 36, 779-787.
11. Furlong, C. E., Cole, T. B., Jarvik, G. P., Pettan-Brewer, C., Geiss, G. K., Richter, R. J., Shih, D. M., Tward, A. D., Lusis, A. J., and Costa, L. G. (2005) Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology 26, 651-659.
12. Fu, A. L., Wang, Y. X., and Sun, M. J. (2005) Naked DNA prevents soman intoxication. Biochem. Biophys. Res. Commun. 328, 901-905.
13. Yeung, D. T., Smith, J. R., Sweeney, R. E., Lenz, D. E., and Cerasoli, D. M. (2007) Direct detection of stereospecific soman hydrolysis by wild-type human serum paraoxonase. FEBS J. 274, 1183-1191.
14. Costa, L. G., Cole, T. B., Vitalone, A., and Furlong, C. E. (2005) Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin. Chim. Acta 352, 37-47.
15. Li, W. F., Costa, L. G., Richter, R. J., Hagen, T., Shih, D. M., Tward, A., Lusis, A. J., and Furlong, C. E. (2000) Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10, 767-779.
16. Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., and Furlong, C. E. (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14, 334-336.
17. Vilanova, E., and Sogorb, M. A. (1999) The role of phosphotriesterases in the detoxication of organophosphorus compounds. Crit. Rev. Toxicol. 29, 21-57.
18. Means, G. E., and Bender, M. (1975) Acetylation of human serum albumin by p-nitrophenyl acetate. Biochemistry 14, 4989-4994.
19. Geldmacher-von Mallinckrodt, M., Hommel, G., and Dumbach, J. (1979) On the genetics of the human serum paraoxonase (EC 3.1.1.2). Hum. Genet. 50, 313-326.
20. Ortigoza-Ferado, J., Richter, R. J., Hornung, S. K., Motulsky, A. G., and Furlong, E. (1984) Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin. Am. J. Hum. Genet. 36, 295-305.
21. Wieseler, S., Schopfer, L., and Lockridge, O. (2006) Markers of organophosphate exposure in human serum. J. Mol. Neurosci. 30, 93-94.
22. Li, B., Schopfer, L. M., Hinrichs, S. H., Masson, P., and Lockridge, O. (2007) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411. Anal. Biochem. 361, 263-272.
23. Carter, W. G., Tarhoni, M., Rathbone, A. J., and Ray, D. E. (2007) Differential protein adduction by seven organophosphorus pesticides in both brain and thymus. Hum. Exp. Toxicol. 26, 347-353.
24. Li, B., Nachon, F., Froment, M. T., Verdier, L., Debouzy, J. C., Brasme, B., Gillon, E., Schopfer, L. M., Lockridge, O., and Masson, P. (2008) Binding and hydrolysis of soman by human serum albumin. Chem. Res. Toxicol. 21, 421-431.
25. Sogorb, M. A., Sellero, I., López-Rivadulla, M., Céspedes, V., and Vilanova, E. (1999) EDTA-resistant and sensitive phosphodiesterase activities associated with albumin and lipoproteins in rabbit serum. Drug Metab. Dispos. 27, 53-59.
26. Sogorb, M. A., Carrera, V., Benebent, M., and Vilanova, E. (2002) Rabbit serum albumin hydrolyzes the carbamate carbaryl. Chem. Res. Toxicol. 15, 520-526.
27. Sogorb, M. A., Carrera, V., and Vilanova, E. (2004) Hydrolysis of carbaryl by human serum albumin. Arch. Toxicol. 78, 629-334.
28. Sogorb, M. A., Díaz-Alejo, N., Escudero, M. A., and Vilanova, E. (1998) Phosphodiesterase activity identified in purified serum albumins. Arch. Toxicol. 72, 219-226.
29. Monroy-Noyola, A., Rojas, P., Vilanova, E., and Sogorb, M. A. (2007) Comparative hydrolysis of O-hexyl O-2,5-dichlorophenyl phosphoramidate and paraoxon in different tissues of vertebrates. Arch. Toxicol. 81, 689-695.
30. Sogorb, M. A., Alvarez-Escalante, C., Carrera, V., and Vilanova, E. (2007) An in vitro approach for demonstrating the critical role of serum albumin in the detoxication of the carbamate carbaryl at in vivo toxicologically relevant concentrations. Arch. Toxicol. 81, 113-119.
31. Ellman, G. L., Courtney, K. D., Andres, V. J. R., and Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
32. Furlong, C. E., Richter, R. J., Seidel, S. L., and Motulsky, A. G. (1988) Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet. 43, 230-238.
33. Peters, T., Jr. (1996) Ligand Binding by Albumin. In All about Albumin. Biochemistry, Genetics, and Medical Applications (Peters, T., Jr., Eds.) pp79-132, Academic Press Inc., San Diego, CA
34. Peters, T., Jr. (1996) Chemical Aspects: Albumin in Medicine. In All about Albumin. Biochemistry, Genetics, and Medical Applications (Peters, T., Jr. Eds.) pp 251-284, Academic Press Inc., San Diego, CA.
35. Chang, S. K., Dauterman, W. C., and Riviere, J. E. (1994) Percutaneous absorption of parathion and its metabolites, paraoxon and p-nitrophenol, administered alone or in combination: in vitro flow-through diffusion cell studies. Pest. Biochem. Physiol. 48, 56-62.
36. WHO (1986) Metabolism and Mode of Action. In Organophosphorus Insecticides: A General Introduction (World Health Organization, Eds.) pp 39-48, World Health Organization, Geneva, Switzerland.
37. Peters, T., Jr. (1996) Metabolism: Albumin in the Body. In All about Albumin, Biochemistry, Genetics, and Medical Applications (Peters, T., Jr., Ed.) pp 188-250, Academic Press Inc., San Diego, CA.
38. Maxwell, D. M., Brecht, K. M., and O'Neill, B. L. (1987) The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 39, 35-42.
39. Li, B., Sedlacek, M., Manoharan, I., Boopathy, R., Duysen, E. G., Masson, P., and Lockridge, O. (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70, 1673-1684.